A recent deal to "bundle" the purchase of 100 Stryker Nuclear Biological Chemical Reconnaissance Vehicles with 292 double-V hull variants already under contract will save the Army nearly $50 million, according to an acquisition decision memorandum obtained by InsideDefense.com.